| 2017 | Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma
| CANCER RESEARCH AND TREATMENT |
| 2008 | Rare translocations involving chromosome band 8p11 in myeloid neoplasms. | CANCER GENETICS AND CYTOGENETICS |
| 2011 | RASSF1A suppresses the activated K-Ras-induced oxidative DNA damage. | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2018 | Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease | HEART RHYTHM |
| 2023 | Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study
| INFECTION AND CHEMOTHERAPY |
| 2017 | Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer
| JOURNAL OF CANCER |
| 2015 | Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells | CELLULAR SIGNALLING |
| 2017 | Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial | CONTEMPORARY CLINICAL TRIALS |
| 2011 | Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry | JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY |
| 2017 | Rationale and design of the Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization: Relation to Cardiovascular Outcomes, Cost Effectiveness and Quality of Life (CONSERVE) trial | AMERICAN HEART JOURNAL |
| 2016 | Rationale and Design of the CREDENCE Trial: computed TomogRaphic evaluation of atherosclerotic DEtermiNants of myocardial IsChEmia
| BMC CARDIOVASCULAR DISORDERS |
| 2022 | Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer | CLINICAL LUNG CANCER |
| 2022 | Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer
| CLINICAL LUNG CANCER |
| 2016 | Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study. | AMERICAN HEART JOURNAL |
| 2013 | Rationale and design of the VICTORY (Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY) trial | JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY |
| 2015 | Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions | CONTEMPORARY CLINICAL TRIALS |
| 2017 | Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
| CANADIAN JOURNAL OF CARDIOLOGY |
| 2019 | Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial | INTERNATIONAL JOURNAL OF STROKE |
| 2010 | Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2017 | Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study | EUROPEAN RADIOLOGY |
